Our findings demonstrated that visfatin treatment led to the down-regulation of miR-2277-3p expression, and introducing the miR-2277-3p mimic into chondrosarcoma cells reversed the visfatin-induced increase in VEGF-D. The gene discussed is NAMPT; the disease is chondrosarcoma.